MEDIo — Medistim ASA Balance Sheet
0.000.00%
- NOK4.13bn
- NOK3.97bn
- NOK562.60m
- 95
- 14
- 98
- 83
Annual balance sheet for Medistim ASA, fiscal year end - December 31st, NOK millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Equivalents | |||||
Cash and Short Term Investments | 71.9 | 129 | 144 | 146 | 171 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 61.2 | 79.6 | 114 | 87.6 | 83.8 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 246 | 306 | 386 | 392 | 429 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 64.7 | 58.9 | 51.3 | 57.3 | 73.2 |
Net Goodwill | |||||
Net Intangible Assets | |||||
Long Term Notes Receivable | |||||
Other Long Term Assets | |||||
Total Assets | 346 | 403 | 483 | 506 | 575 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 59.5 | 77.6 | 99.8 | 94.3 | 107 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Total Other Liabilities | |||||
Total Liabilities | 89 | 97.2 | 115 | 108 | 138 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Treasury Stock | |||||
Other Equity | |||||
Total Equity | 257 | 306 | 368 | 398 | 437 |
Total Liabilities & Shareholders' Equity | 346 | 403 | 483 | 506 | 575 |
Total Common Shares Outstanding |